Table 2.
Clinical characteristics of healthy individuals in the cutoff selection and evaluation test
| Healthy individuals Cutoff setting test |
Healthy individuals Clinical performance test for cutoff evaluation of the apoA2-i ELISA kit for IVD |
|
|---|---|---|
| Sex | ||
| N | 2000 | 400 |
| Male | 1025 | 205 |
| Female | 975 | 195 |
| Age (y) | ||
| N | 2000 | 400 |
| Mean (SD) | 62.9 (8.0) | 63.4 (8.6) |
| Median | 63 | 63 |
| Min, Max | 49, 91 | 49, 94 |
| Height (cm) | ||
| N | 1522 | 320 |
| Mean (SD) | 161.51 (8.60) | 160.76 (8.75) |
| Median | 161.4 | 160.35 |
| Min, Max | 134.0, 184.4 | 139.5, 180.3 |
| Weight (kg) | ||
| N | 1522 | 320 |
| Mean (SD) | 61.38 (11.79) | 60.40 (11.55) |
| Median | 60.6 | 59.75 |
| Min, Max | 32.9, 120.0 | 36.7, 110.3 |
| BS (mg/dL) | ||
| N | 1512 | 318 |
| Mean (SD1) | 102.6 (18.5) | 102.7 (16.6) |
| Median | 98 | 99 |
| Min, Max | 73, 313 | 78, 252 |
| HbA1c (%) | ||
| N | 1505 | 314 |
| Mean (SD) | 5.60 (0.59) | 5.65 (0.63) |
| Median | 5.5 | 5.5 |
| Min, Max | 4.5, 11.2 | 4.4, 9.7 |
| Amylase (U/L) | ||
| N | 1008 | 228 |
| Mean (SD) | 80.0 (29.6) | 80.6 (32.1) |
| Median | 74 | 75.5 |
| Min, Max | 26, 320 | 33, 359 |
| HDL (mg/dL) | ||
| N | 1522 | 320 |
| Mean (SD) | 63.9 (16.7) | 63.5 (15.5) |
| Median | 62 | 62 |
| Min, Max | 25,126 | 33, 119 |
| LDL (mg/dL) | ||
| N | 1522 | 320 |
| Mean (SD) | 127.5 (30.1) | 128.4 (38.8) |
| Median | 126 | 127 |
| Min, Max | 35, 256 | 43, 546 |
SD standard deviation, BS blood sugar, HDL high-density lipoprotein, LDL low-density lipoprotein